Prostate Cancer Trials Face Randomization Challenges In U.S.
This article was originally published in The Gray Sheet
Executive Summary
Device marketing, patient preferences, physician bias and financial incentives can thwart attempts by comparative effectiveness researchers to randomize prostate cancer patients into clinical trials.